The effect of decreasing the dosage of cyclosporine A 0.05% on dry eye disease after 1 year of twice-daily therapy.

scientific article published in October 2011

The effect of decreasing the dosage of cyclosporine A 0.05% on dry eye disease after 1 year of twice-daily therapy. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/ICO.0B013E318206CAEE
P698PubMed publication ID21407074

P2093author name stringGerard D'Aversa
Henry D Perry
John R Wittpenn
Eric D Donnenfeld
Allon Barsam
Alicia R Perry
Michael Y Su
P433issue10
P921main subjectcyclosporineQ367700
eye diseaseQ3041498
P304page(s)1098-1104
P577publication date2011-10-01
P1433published inCorneaQ15760110
P1476titleThe effect of decreasing the dosage of cyclosporine A 0.05% on dry eye disease after 1 year of twice-daily therapy.
P478volume30

Reverse relations

cites work (P2860)
Q34273377Cataract surgery in patients with ocular surface disease: An update in clinical diagnosis and treatment
Q39151688Clinical utility of cyclosporine (CsA) ophthalmic emulsion 0.05% for symptomatic relief in people with chronic dry eye: a review of the literature
Q57378488Current and emerging therapy of dry eye disease. Part A: pharmacological modalities
Q35570541Cyclosporine ophthalmic emulsions for the treatment of dry eye: a review of the clinical evidence
Q92824372Dry Eye Disease: A Review of Epidemiology in Taiwan, and its Clinical Treatment and Merits
Q36252489Dysfunctional tear syndrome: dry eye disease and associated tear film disorders - new strategies for diagnosis and treatment
Q35805082Expert opinion in the management of aqueous Deficient Dry Eye Disease (DED).
Q53534950Keratitis in Dry Eye Disease and Topical Ciclosporin A.
Q36444344PERSIST: Physician's Evaluation of Restasis(®) Satisfaction in Second Trial of topical cyclosporine ophthalmic emulsion 0.05% for dry eye: a retrospective review
Q52608828Patient and physician perspectives on the use of cyclosporine ophthalmic emulsion 0.05% for the management of chronic dry eye.
Q91905513Practical guidance for the use of cyclosporine ophthalmic solutions in the management of dry eye disease
Q38584878Recommendations for the treatment of Sjögren's syndrome
Q38171801Systematic review of randomised clinical trials on topical ciclosporin A for the treatment of dry eye disease.
Q90093016Topical cyclosporine A therapy for dry eye syndrome

Search more.